These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 10662810)

  • 21. Predictive testing for hereditary breast and ovarian cancer: a psychological framework for pre-test counselling.
    Decruyenaere M; Evers-Kiebooms G; Denayer L; Welkenhuysen M; Claes E; Legius E; Demyttenaere K
    Eur J Hum Genet; 2000 Feb; 8(2):130-6. PubMed ID: 10757645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A
    Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic evaluation of the familial cancer programme in Western Australia: predictive genetic testing for familial adenomatous polyposis and hereditary non-polyposis colorectal carcinoma.
    Breheny N; Geelhoed E; Goldblatt J; Ee H; O'Leary P
    Community Genet; 2006; 9(2):98-106. PubMed ID: 16612060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Genetic testing when tumor susceptibility, especially for colorectal cancer, is suspected].
    Müller H
    Ther Umsch; 2003 Aug; 60(8):445-53. PubMed ID: 14502851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The introduction of a choice to learn pre-symptomatic DNA test results for BRCA or Lynch syndrome either face-to-face or by letter.
    Voorwinden JS; Jaspers JP; ter Beest JG; Kievit Y; Sijmons RH; Oosterwijk JC
    Clin Genet; 2012 May; 81(5):421-9. PubMed ID: 22091929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer.
    Gritz ER; Peterson SK; Vernon SW; Marani SK; Baile WF; Watts BG; Amos CI; Frazier ML; Lynch PM
    J Clin Oncol; 2005 Mar; 23(9):1902-10. PubMed ID: 15774782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Motivations and psychosocial impact of genetic testing for HNPCC.
    Esplen MJ; Madlensky L; Butler K; McKinnon W; Bapat B; Wong J; Aronson M; Gallinger S
    Am J Med Genet; 2001 Sep; 103(1):9-15. PubMed ID: 11562928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures.
    Wagner A; van Kessel I; Kriege MG; Tops CM; Wijnen JT; Vasen HF; van der Meer CA; van Oostrom II; Meijers-Heijboer H
    Fam Cancer; 2005; 4(4):295-300. PubMed ID: 16341806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hereditary colorectal carcinomas - reflection on preventive surgery].
    Pistorius S; Schackert HK; Saeger HD
    Onkologie; 2001 Sep; 24 Suppl 5():4-8. PubMed ID: 11600806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetic aspects of colorectal cancer].
    Abramowicz M
    Rev Med Brux; 2001 Sep; 22(4):A199-202. PubMed ID: 11680173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Factors for Distress After Genetic Testing for Hereditary Cancer.
    Voorwinden JS; Jaspers JP
    J Genet Couns; 2016 Jun; 25(3):495-503. PubMed ID: 26475052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations.
    Halbert CH; Lynch H; Lynch J; Main D; Kucharski S; Rustgi AK; Lerman C
    Arch Intern Med; 2004 Sep; 164(17):1881-7. PubMed ID: 15451763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary non-polyposis colorectal cancer/Lynch syndrome in three dimensions.
    Kravochuck SE; Church JM
    ANZ J Surg; 2017 Dec; 87(12):1006-1010. PubMed ID: 26990828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coping style, psychological distress, risk perception, and satisfaction in subjects attending genetic counselling for hereditary cancer.
    Nordin K; Lidén A; Hansson M; Rosenquist R; Berglund G
    J Med Genet; 2002 Sep; 39(9):689-94. PubMed ID: 12205115
    [No Abstract]   [Full Text] [Related]  

  • 35. Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer.
    Meiser B; Collins V; Warren R; Gaff C; St John DJ; Young MA; Harrop K; Brown J; Halliday J
    Clin Genet; 2004 Dec; 66(6):502-11. PubMed ID: 15521977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Predictive genetic testing for hereditary breast cancer and hereditary nonpolyposis colorectal cancer].
    Heyll U; Slany E
    Versicherungsmedizin; 2007 Sep; 59(3):129-35. PubMed ID: 17912887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of outpatient management in HNPCC].
    Bach K; Hüppe D; Schmiegel W; Epplen JT; Kunstmann E
    Z Gastroenterol; 2005 Jul; 43(7):647-51. PubMed ID: 16001346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic counselling and consent for tumour testing in HNPCC.
    Gaff CL; Rogers MT; Frayling IM
    Clin Genet; 2007 May; 71(5):400-5. PubMed ID: 17489844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations.
    Barrow E; Alduaij W; Robinson L; Shenton A; Clancy T; Lalloo F; Hill J; Evans DG
    Clin Genet; 2008 Sep; 74(3):233-42. PubMed ID: 18554281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic testing offered directly after the diagnosis of colorectal cancer: a pilot study on the reactions of patients.
    Landsbergen KM; Prins JB; Brunner HG; Hoogerbrugge N
    Genet Couns; 2009; 20(4):317-25. PubMed ID: 20162866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.